Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity-Reference-Cited by-同舟云学术

Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity

Published:2020-07-06 Issue:6 Volume:4 Page:1035-1045
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Wang Michael¹^ORCID,Recht Michael²^ORCID,Iyer Neeraj N.³^ORCID,Cooper David L.³^ORCID,Soucie J. Michael⁴^ORCID

Affiliation:

1. Hemophilia and Thrombosis Center University of Colorado School of Medicine Aurora Colorado USA

2. The Hemophilia Center at Oregon Health & Science University Portland Oregon USA

3. Novo Nordisk Inc.Clinical, Medical, and Regulatory Affairs Plainsboro New Jersey USA

4. Centers for Disease Control and Prevention Atlanta Georgia USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12347

Reference38 articles.

1. Guidelines for the management of hemophilia

2. Centers for Disease Control and Prevention HTC Population Profile ‐ January 2012 to March 2019. 2019.[Accessed 2017 September 7] Available from:https://www.cdc.gov/ncbddd/hemophilia/communitycounts/data‐reports/2019‐3

3. Pathogenesis of haemophilic arthropathy

4. National Hemophilia Foundation Medical and Scientific Advisory Council Recommendation #241 Concerning Prophylaxis ‐ Regular Administration of Clotting Factor Concentrate to Prevent Bleeding. www.hemophilia.org: National Hemophilia Foundation; February 27 2016. [Accessed 2017 July 26] Available from:https://www.hemophilia.org/sites/default/files/document/files/241Prophylaxis.pdf.

5. Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concizumab improves clot formation in hemophilia A under flow;Journal of Thrombosis and Haemostasis;2024-09

2. Clinical and Humanistic Burden of Non-inhibitor Haemophilia A in Five European Countries: Insights from the CHESS II Study;Advances in Therapy;2024-08-17

3. Joint health and pain in the changing hemophilia treatment landscape;Expert Review of Hematology;2024-07-15

4. Patient perspective on living with mild hemophilia in Germany: results from a nationwide survey;Frontiers in Medicine;2024-02-05

5. Advancements in haemophilia A and health equity: is it time to redefine severity?;The Lancet Haematology;2024-02